China Resources Pharmaceutical (03320.HK): China Resources Pharmaceutical Holdings' net profit attributable to parent for the first three quarters was RMB 2.391 billion, down 6.73% year on year.

Zhito Finance APP News, China Resources Pharmaceutical (03320.HK) released the results of China Resources Pharmaceutical Holdings for the nine months ended September 30, 2026. The company achieved operating revenue of RMB 203.528 billion, an increase of 1.32% year-on-year; net profit attributable to owners of the parent company was RMB 2.391 billion, a decrease of 6.73% year-on-year.